Erica Mayer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Erica Mayer
Dec 10, 2024, 11:06 | Insight
Dana-Farber Researchers to Present at the 2024 San Antonio Breast Cancer Symposium
Researchers from Dana-Farber Cancer Institute will present over 30 studies at the 47th Annual San…
Dec 2, 2024, 12:31 | Insight
10 presentations not to miss from SABCS 2024 suggested by Paolo Tarantino
The SABCS 2024 (San Antonio Breast Cancer Symposium) will take place from December 10th to…
Nov 10, 2024, 16:37 | Insight
Incorporation of immunotherapy in the management of early-stage ER+ Breast Cancer
A recent paper by Guilherme Nader-Marta, Clinical Fellow at Dana-Farber Cancer Institute, was mentioned by…
Nov 4, 2024, 13:32 | Insight
Paolo Tarantino: The SERENA-2 phase 2 trial of camizestrant vs fulvestrant is out
Paolo Tarantino, Research Fellow at The Dana-Farber Cancer Institute, shared on X: “The SERENA-2 phase…
Oct 8, 2024, 17:26 | Insight
Paolo Tarantino: The largest HER2-low sub-analysis of a RCT led by Guilherme Nader-Marta
Paolo Tarantino shared a recent article by Guilherme Nader-Marta et al. published in Breast Cancer…
Aug 7, 2024, 19:44 | Blog
Erica Mayer and Rachel Freedman leading efforts to increase Diversity In Research - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "At  Dana Farber we are dedicated…
May 23, 2024, 10:28 | Blog
In a recent interview Dr. Erica Mayer discussed tamoxifen and aromatase inhibitors - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "In a recent Health Reporter interview…
Mar 24, 2024, 08:23 | Drugs
Paolo Tarantino: Adding palbociclib to fulvestrant did not improve PFS in the PACE randomized phase 2 trial
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Nov 8, 2023, 18:09 | Societies
ASCO has been awarded an $11 million grant from PCORI to support a clinical trial co-led by Erica Mayer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "The American Society of Clinical Oncology (ASCO) has been awarded an $11…
All: 9 Posts: 1 - 100
Special Coverage